Another attempt to kill ivermectin for the treatment of Covid?

Oxford University is the NIAID of the UK–as far as deliberate prevention of effective treatment for Covid goes.  Think HCQ poisonings. The two principal investigators fo the Recovery trial (Peter Horby and Martin Landray) are Oxford professors, who dosed people with sufficient HCQ that more patients died in the treatment arm than in the placebo (untreated) arm of the trial.  They also designed things so the drug was given too late, when the viral titers were gone, autoimmune effects were causing the late signs of damage, and HCQ would no longer be effective.

Think Astra-Zeneca’s adenovirus vectored Covid vaccine, developed by Sarah Gilbert and Adrian Hill at Oxford.  Adenovirus vaccines were known to cause blood clots even before Covid existed.  Yet it was the only vaccine offered to most people in the UK.

Now Oxford is lending its expertise to the study of outpatient ivermectin.  Do you think it will redeem itself with an honest and ethical study, or try to tank the drug?  Do you think it will finally follow a moral compass?  Stay tuned, as will I.

Notify of
Inline Feedbacks
View all comments
Scroll to Top